Boai NKY Pharmaceuticals Ltd (300109) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.038x

Based on the latest financial reports, Boai NKY Pharmaceuticals Ltd (300109) has a cash flow conversion efficiency ratio of 0.038x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥139.46 Million ≈ $20.41 Million USD) by net assets (CN¥3.69 Billion ≈ $540.03 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Boai NKY Pharmaceuticals Ltd - Cash Flow Conversion Efficiency Trend (2007–2024)

This chart illustrates how Boai NKY Pharmaceuticals Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Boai NKY Pharmaceuticals Ltd debt and liabilities for a breakdown of total debt and financial obligations.

Boai NKY Pharmaceuticals Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Boai NKY Pharmaceuticals Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Anhui Shanying Paper Industry Co Ltd SHG:600567	0.044x
Beijing Sanyuan Foods Co Ltd SHG:600429	0.034x
Develia S.A WAR:DVL	0.028x
Shenzhen Sunrise New Energy Co Ltd SHE:002256	0.036x
Shanghai Chengdi Constr Co SHG:603887	0.201x
Derichebourg PA:DBG	0.205x
Rami Levi TA:RMLI	0.250x
MBX Biosciences, Inc. Common Stock NASDAQ:MBX	-0.056x

Annual Cash Flow Conversion Efficiency for Boai NKY Pharmaceuticals Ltd (2007–2024)

The table below shows the annual cash flow conversion efficiency of Boai NKY Pharmaceuticals Ltd from 2007 to 2024. For the full company profile with market capitalisation and key ratios, see 300109 market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥3.61 Billion ≈ $527.92 Million	CN¥256.03 Million ≈ $37.47 Million	0.071x	-48.84%
2023-12-31	CN¥3.52 Billion ≈ $515.09 Million	CN¥488.25 Million ≈ $71.45 Million	0.139x	+71.74%
2022-12-31	CN¥3.12 Billion ≈ $456.15 Million	CN¥251.77 Million ≈ $36.84 Million	0.081x	+532.17%
2021-12-31	CN¥3.40 Billion ≈ $497.55 Million	CN¥43.44 Million ≈ $6.36 Million	0.013x	-85.27%
2020-12-31	CN¥3.08 Billion ≈ $450.15 Million	CN¥266.87 Million ≈ $39.05 Million	0.087x	+232.53%
2019-12-31	CN¥3.05 Billion ≈ $446.69 Million	CN¥79.64 Million ≈ $11.65 Million	0.026x	-31.79%
2018-12-31	CN¥1.28 Billion ≈ $186.75 Million	CN¥48.81 Million ≈ $7.14 Million	0.038x	+5.36%
2017-12-31	CN¥1.30 Billion ≈ $190.58 Million	CN¥47.28 Million ≈ $6.92 Million	0.036x	-60.99%
2016-12-31	CN¥1.23 Billion ≈ $179.49 Million	CN¥114.14 Million ≈ $16.70 Million	0.093x	+68.78%
2015-12-31	CN¥1.16 Billion ≈ $170.16 Million	CN¥64.12 Million ≈ $9.38 Million	0.055x	-52.64%
2014-12-31	CN¥400.25 Million ≈ $58.57 Million	CN¥46.60 Million ≈ $6.82 Million	0.116x	+89.44%
2013-12-31	CN¥377.06 Million ≈ $55.18 Million	CN¥23.17 Million ≈ $3.39 Million	0.061x	+8.28%
2012-12-31	CN¥363.81 Million ≈ $53.24 Million	CN¥20.65 Million ≈ $3.02 Million	0.057x	+405.33%
2011-12-31	CN¥350.93 Million ≈ $51.35 Million	CN¥3.94 Million ≈ $576.77K	0.011x	-62.77%
2010-12-31	CN¥333.21 Million ≈ $48.76 Million	CN¥10.05 Million ≈ $1.47 Million	0.030x	-93.44%
2009-12-31	CN¥62.14 Million ≈ $9.09 Million	CN¥28.57 Million ≈ $4.18 Million	0.460x	+593.63%
2008-12-31	CN¥43.93 Million ≈ $6.43 Million	CN¥-4.09 Million ≈ $-598.80K	-0.093x	-117.36%
2007-12-31	CN¥17.82 Million ≈ $2.61 Million	CN¥9.56 Million ≈ $1.40 Million	0.536x	--

About Boai NKY Pharmaceuticals Ltd

SHE:300109 China Specialty Chemicals

Market Cap

$1.34 Billion

CN¥9.15 Billion CNY

Market Cap Rank

#7853 Global

#1953 in China

Share Price

CN¥18.92

Change (1 day)

-0.05%

52-Week Range

CN¥15.65 - CN¥20.47

All Time High

CN¥149.39